TCL Archive Despite NCI director’s enthusiasm, “We have a long way to go before we beat cancer,” the former NIH director says. May 20, 2005
TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014